BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai A, Wu C, Liu X, Lv H, Xu X, Cao Y, Shang W, Hu L, Liu Y. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate. Drug Des Devel Ther 2018;12:2129-38. [PMID: 30022811 DOI: 10.2147/DDDT.S166989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Behzadnia M, Salmanpour M, Heidari M, Monajati M, Farjadian F, Abedi M, Tamaddon AM. Sorafenib tosylate incorporation into mesoporous starch xerogel for in-situ micronization and oral bioavailability enhancement. Drug Dev Ind Pharm 2022;:1-12. [PMID: 36066848 DOI: 10.1080/03639045.2022.2113405] [Reference Citation Analysis]
2 Eseva EA, Lukashov MO, Cherednichenko KA, Levin IS, Akopyan AV. Heterogeneous Catalysts Containing an Anderson-Type Polyoxometalate for the Aerobic Oxidation of Sulfur-Containing Compounds. Ind Eng Chem Res 2021;60:14154-65. [DOI: 10.1021/acs.iecr.1c03201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Mehmood Y, Khan IU, Shahzad Y, Khan RU, Iqbal MS, Khan HA, Khalid I, Yousaf AM, Khalid SH, Asghar S, Asif M, Hussain T, Shah SU. In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement. Pharmaceutics 2020;12:E307. [PMID: 32231052 DOI: 10.3390/pharmaceutics12040307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]